Argenx
ARGX
HK$4,769
Share price
2.37%
Change (1 day)
62.31%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) - Net assets
Net assets on the balance sheet as of December 2024 : HK$42.64 Billion
According to Argenx
's latest financial reports the company has HK$42.64 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Argenx - Net assets on balance sheet (from 2021 to 2020)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $HK$42.68 B | 33.39% |
| 2023-12-31 | $HK$32.00 B | 45.57% |
| 2022-12-31 | $HK$21.98 B | 11.25% |
| 2021-12-31 | $HK$19.76 B | 23.8% |
| 2020-12-31 | $HK$15.96 B | 55% |
| 2019-12-31 | $HK$10.29 B | 86.66% |
| 2018-12-31 | $HK$5.51 B | 42.23% |
| 2017-12-31 | $HK$3.87 B | 613.57% |
| 2016-12-31 | $HK$0.54 B | 57.4% |
| 2015-12-31 | $HK$0.34 B | -39.88% |
| 2014-12-31 | $HK$0.57 B | 78.99% |
| 2013-12-31 | $HK$0.32 B | 87.99% |
| 2012-12-31 | $HK$0.17 B | -39.33% |
| 2011-12-31 | $HK$0.28 B | 165.67% |
| 2010-12-31 | $HK$0.10 B |